Novel Corona Virus (nCOVID-19; India): Chain Reaction Disease (CRD); Precaution-Prevention, Treatment A Review

References (21)

1. 1 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
2. 2 First Case of 2019 Novel Coronavirus in the United States [DOI]
3. 3 RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [DOI]
4. 4 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [DOI]
5. 5 Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study [DOI]
6. 6 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro [DOI]
7. 7 Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area [DOI]
8. 8 A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong [DOI]
9. 9 [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. [DOI]
10. 10 Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.
11. 11 Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China [DOI]
12. 12 Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study [DOI]
13. 13 Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts [DOI]
14. 14 A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 [DOI]
15. 15 Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial [DOI]
16. 16 Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak [DOI]
17. 17 Global virus outbreaks: Interferons as 1st responders [DOI]
18. 18 In vitro inhibition of human influenza A virus replication by chloroquine. [DOI]
19. 19 Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003 [DOI]
20. 20 Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy [DOI]
21. 21 [Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro].

Cited by 0

No indexed citations yet.

Related research

• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Colorectal Cancer Risk and Prevention Knowledge among Adults Attending Public Health Facilities in Obudu, Cross River State, Nigeria — shares topic coverage
• Sociocultural Factors Influencing Malaria Prevention and Treatment Pathways among Pregnant Women in the Foumban Health District, Cameroon — shares topic coverage
• "In vitro" Evaluation of Some Properties in Spore Former Bacteria Isolated from Calves Faeces — shares topic coverage
• Evaluation of Hygiene Practices among Medical Staff Using Mobile Phones at Yaoundé General Hospital: Implications for Infection and Sepsis Prevention — shares topic coverage